Makriyannis, Alexandros
- Florida International University · Microbiology & Immunology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #31,626
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Microbiology & Immunology
NIH Funding · FY2023
Linked Award Amount
$370.6K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#31,626
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Makriyannis, Alexandros as a PI. Multi-PI records show the full award amount for context.
- 5R01DA052271-04R01Contact PITargeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoidFlorida International University · Microbiology & Immunology (NIH department code)$370.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Makriyannis, Alexandros as a PI.
FY2023 award administered by Florida International University (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardFlorida International University
- 2001$500K Cumulative Funding
- 2001$1M Cumulative Funding
- 2001$2M Cumulative Funding
- 2001Entered Top 50% NationallyRanked #833
- 2001Entered Top 25% NationallyRanked #833
- 2001Entered Top 10% NationallyRanked #833
- 2001Entered Top 5% NationallyRanked #833
- 2003$5M Cumulative Funding
- 2004R01 Grant Holder
- 2005$10M Cumulative Funding